최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Translational psychiatry, v.10 no.1, 2020년, pp.156 -
Kim, Yangsik (Department of Psychiatry, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea) , Lee, Jung Sun (Department of Psychiatry, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea) , Joo, Yeon Ho (Department of Psychiatry, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea)
Rapamycin inhibits protein translation in cells, including neural stem cells (NSCs), by suppressing the mechanistic target of rapamycin (mTOR). This drug has been widely used together with calcineurin inhibitors in transplantation patients to prevent graft rejection. Previous studies have reported a...
1. Badve SV Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients Clin. J. Am. Soc. Nephrol. 2016 11 1845 1855 10.2215/CJN.00190116 27445164
2. Basu A., Shapiro R. Tacrolimus in renal transplantation. Kidney Transplant. 259–276. https://www.elsevier.com/books/kidney-transplantation/morris/978-1-4160-3343-1 (2008).
3. Saxton RA Sabatini DM mTOR signaling in growth, metabolism, and disease Cell 2017 168 960 976 10.1016/j.cell.2017.02.004 28283069
4. Dwyer JM Duman RS Activation of mammalian target of rapamycin and synaptogenesis: Role in the actions of rapid-acting antidepressants Biol. Psychiatry 2013 73 1189 1198 10.1016/j.biopsych.2012.11.011 23295207
5. Licausi F Hartman NW Role of mTOR complexes in neurogenesis Int. J. Mol. Sci. 2018 19 E1544 10.3390/ijms19051544 29789464
6. Crino PB Nathanson KL Henske EP The tuberous sclerosis complex N. Engl. J. Med. 2006 355 1345 1356 10.1056/NEJMra055323 17005952
7. Zordan P Tuberous sclerosis complex–associated CNS abnormalities depend. hyperactivation mTORC1 Akt J. Clin. Invest. 2018 128 1688 1706 10.1172/JCI96342 29389670
8. Crino PB The mTOR signalling cascade: paving new roads to cure neurological disease Nat. Rev. Neurol. 2016 12 379 10.1038/nrneurol.2016.81 27340022
9. Jernigan CS The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder Prog. Neuropsychopharmacol. Biol. Psychiatry 2011 35 1774 1779 10.1016/j.pnpbp.2011.05.010 21635931
10. Feyissa AM Chandran A Stockmeier CA Karolewicz B Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression Prog. Neuropsychopharmacol. Biol. Psychiatry 2009 33 70 75 10.1016/j.pnpbp.2008.10.005 18992785
11. Newport DJ Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression Am. J. Psychiatry 2015 172 950 966 10.1176/appi.ajp.2015.15040465 26423481
12. Abelaira HM Réus GZ Neotti MV Quevedo J The role of mTOR in depression and antidepressant responses Life Sci. 2014 101 10 14 10.1016/j.lfs.2014.02.014 24582593
13. Li N mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists Science 2010 329 959 964 10.1126/science.1190287 20724638
14. Autry AE NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses Nature 2011 475 91 10.1038/nature10130 21677641
15. Zarate CA A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression Arch. Gen. Psychiatry 2006 63 856 864 10.1001/archpsyc.63.8.856 16894061
16. Zanos P NMDAR inhibition-independent antidepressant actions ketamine metabolites Nature 2016 533 481 10.1038/nature17998 27144355
17. Duman RS Li N Liu R-J Duric V Aghajanian G Signaling pathways underlying the rapid antidepressant actions of ketamine Neuropharmacology 2012 62 35 41 10.1016/j.neuropharm.2011.08.044 21907221
18. Berman RM Antidepressant effects of ketamine in depressed patients Biol. Psychiatry 2000 47 351 354 10.1016/S0006-3223(99)00230-9 10686270
19. Li N Glutamate N -methyl- d -aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure Biol. Psychiatry 2011 69 754 761 10.1016/j.biopsych.2010.12.015 21292242
20. Krishnan V Nestler EJ Linking molecules to mood: new insight into the biology of depression Am. J. Psychiatry 2010 167 1305 1320 10.1176/appi.ajp.2009.10030434 20843874
21. Sarbassov DD Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB Mol. Cell 2006 22 159 168 10.1016/j.molcel.2006.03.029 16603397
22. Arriola Apelo SI Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system Aging Cell 2016 15 28 38 10.1111/acel.12405 26463117
23. Boldrini M Hippocampal granule neuron number and dentate gyrus volume in antidepressant-treated and untreated major depression Neuropsychopharmacology 2013 38 1068 10.1038/npp.2013.5 23303074
24. Sahay A Drew MR Hen R Dentate gyrus neurogenesis and depression Prog. Brain Res. 2007 163 697 822 10.1016/S0079-6123(07)63038-6 17765746
25. Hutton SR Pevny LH SOX2 expression levels distinguish between neural progenitor populations of the developing dorsal telencephalon Dev. Biol. 2011 352 40 47 10.1016/j.ydbio.2011.01.015 21256837
26. Butler CR Boychuk JA Smith BN Effects of rapamycin treatment on neurogenesis and synaptic reorganization in the dentate gyrus after controlled cortical impact injury in mice Front. Syst. Neurosci. 2015 9 163 163 10.3389/fnsys.2015.00163 26640431
27. Duman RS Neurobiology of stress, depression, and rapid acting antidepressants: remodeling synaptic connections Depression Anxiety 2014 31 291 296 10.1002/da.22227 24616149
28. Sato A Regulation of neural stem/progenitor cell maintenance by PI3K and mTOR Neurosci. Lett. 2010 470 115 120 10.1016/j.neulet.2009.12.067 20045038
29. Deschwanden A Reduced metabotropic glutamate receptor 5 density in major depression determined by [11C] ABP688 PET and postmortem study Am. J. Psychiatry 2011 168 727 734 10.1176/appi.ajp.2011.09111607 21498461
30. Yang C Mechanistic target of rapamycin–independent antidepressant effects of (R)-ketamine in a social defeat stress model Biol. Psychiatry 2018 83 18 28 10.1016/j.biopsych.2017.05.016 28651788
31. Chilcot J Spencer BWJ Maple H Mamode N Depression and kidney transplantation Transplantation 2014 97 717 721 10.1097/01.TP.0000438212.72960.ae 24342977
32. Zalai D Szeifert L Novak M Psychological distress and depression in patients with chronic kidney disease Semin. Dialysis 2012 25 428 438 10.1111/j.1525-139X.2012.01100.x
33. Hadamitzky M Repeated systemic treatment rapamycin affects behavior and amygdala protein expression in rats Int. J. Neuropsychopharmacol. 2018 21 592 602 10.1093/ijnp/pyy017 29462337
34. Ting, J. T., Daigle, T. L., Chen, Q. & Feng G. in Patch-Clamp Methods and Protocols p. 221–242 (Springer 2014).
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.